{
    "1634252787998490624": {
        "attachments": {
            "media_keys": [
                "3_1634252784705871889"
            ]
        },
        "author_id": "62465691",
        "created_at": "2023-03-10T18:00:02.000Z",
        "edit_history_tweet_ids": [
            "1634252787998490624"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 35,
                    "normalized_text": "kidney disease",
                    "probability": 0.6929,
                    "start": 22,
                    "type": "Other"
                },
                {
                    "end": 40,
                    "normalized_text": "CKD",
                    "probability": 0.4795,
                    "start": 38,
                    "type": "Other"
                },
                {
                    "end": 149,
                    "normalized_text": "AstraZeneca",
                    "probability": 0.9382,
                    "start": 139,
                    "type": "Organization"
                },
                {
                    "end": 157,
                    "normalized_text": "CKD",
                    "probability": 0.6624,
                    "start": 155,
                    "type": "Organization"
                },
                {
                    "end": 255,
                    "normalized_text": "Economist Impact",
                    "probability": 0.6351,
                    "start": 240,
                    "type": "Other"
                }
            ],
            "mentions": [
                {
                    "end": 103,
                    "id": "29998941",
                    "start": 87,
                    "username": "economistimpact"
                }
            ],
            "urls": [
                {
                    "display_url": "spr.ly/60143FlQg",
                    "end": 280,
                    "expanded_url": "http://spr.ly/60143FlQg",
                    "start": 257,
                    "url": "https://t.co/LxwT01cFD1"
                },
                {
                    "display_url": "pic.twitter.com/LEuZGhqial",
                    "end": 304,
                    "expanded_url": "https://twitter.com/AstraZeneca/status/1634252787998490624/photo/1",
                    "media_key": "3_1634252784705871889",
                    "start": 281,
                    "url": "https://t.co/LEuZGhqial"
                }
            ]
        },
        "id": "1634252787998490624",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 28556,
            "like_count": 29,
            "quote_count": 4,
            "reply_count": 15,
            "retweet_count": 7
        },
        "text": "Prevalence of chronic kidney disease (CKD) is rising, yet it is under diagnosed. A new @economistimpact report, initiated and supported by AstraZeneca, on CKD highlights the need for global and local policy changes. Read the full report at Economist Impact:https://t.co/LxwT01cFD1 https://t.co/LEuZGhqial"
    }
}